Today: 9 June 2026
Browse Category

NYSE:AU 29 December 2025 - 24 February 2026

AngloGold Ashanti stock jumps 6% to a fresh high as gold swings and dividend dates come into focus

AngloGold Ashanti stock jumps 6% to a fresh high as gold swings and dividend dates come into focus

AngloGold Ashanti shares closed up 6% at $121.12 Monday after gold surged on U.S. tariff headlines, then slipped Tuesday as bullion prices fell over 1%. The company corrected a dividend date error, confirming March 13, 2026, as the record date. AngloGold recently reported a near tripling in annual profit and new reserves at its Nevada project.
24 February 2026
···
Newmont stock price today: NEM cools after Tuesday pop as gold breaks $4,800

Newmont stock price today: NEM cools after Tuesday pop as gold breaks $4,800

Spot gold hit a record $4,887.82 an ounce Wednesday as geopolitical tensions rose over Trump’s Greenland bid. Newmont shares edged up 0.2% to $119.17 in afternoon trading after a volatile session. Agnico Eagle, Franco-Nevada, AngloGold Ashanti, and Gold Fields all slipped. Europe called an emergency summit for Thursday on the Greenland dispute.
21 January 2026
·······
Gold Fields stock jumps as gold breaks $4,600; CPI and earnings in focus

Gold Fields stock jumps as gold breaks $4,600; CPI and earnings in focus

Gold Fields shares surged 6.7% to $48.73 in New York Monday after gold prices hit a record high, prompting gains across gold miners. The rally followed safe-haven buying and a weaker dollar ahead of Tuesday’s U.S. inflation report. Gold Fields earlier touched $49.58, with Newmont, AngloGold Ashanti, and Wheaton Precious Metals also advancing. Investors await CPI data for clues on rates and sector momentum.
12 January 2026
·······
Gold price smashes $4,600 record and gold stocks jump — here’s what traders watch next

Gold price smashes $4,600 record and gold stocks jump — here’s what traders watch next

Newmont jumped nearly 4% Monday as gold hit a record above $4,600 an ounce amid political unrest and a standoff over Fed Chair Jerome Powell. The dollar index fell 0.4% to 98.84 after Powell disclosed subpoenas tied to his testimony. Gold futures rose 2.1% to $4,596.70, while the SPDR Gold Shares ETF gained 2.4%. Investors are watching U.S. CPI data and the Fed meeting on Jan. 27-28.
12 January 2026
·····
Gold price slips ahead of U.S. jobs data as Newmont stock and GLD track bullion

Gold price slips ahead of U.S. jobs data as Newmont stock and GLD track bullion

Spot gold dropped 0.6% to $4,427.48 an ounce Thursday as funds positioned ahead of the Bloomberg Commodity Index rebalancing and the dollar strengthened. Newmont shares slipped 1.1% premarket, while SPDR Gold Shares lost 1%. HSBC projected gold could reach $5,000 in early 2026 but warned of a possible correction if Fed rate cuts stall.
8 January 2026
·······
Gold price today rebounds after Monday plunge; Newmont stock, GLD ETF rise

Gold price today rebounds after Monday plunge; Newmont stock, GLD ETF rise

Spot gold rebounded to $4,380 an ounce Tuesday morning after Monday’s sharp selloff, up about 0.9% on the day, JM Bullion data showed. Newmont rose 0.6% and SPDR Gold Shares gained 0.5%. Investors are awaiting the Federal Reserve’s December meeting minutes for signals on 2026 rate cuts. China’s net gold imports via Hong Kong more than doubled in November to 16.16 metric tons.
30 December 2025
······

Stock Market Today

  • Nuvalent Shares Surge Near $124 Following GSK's $10.6 Billion Buyout Offer
    June 9, 2026, 10:35 AM EDT. Nuvalent's stock jumped 38.9% to $122.93 after GSK announced a $10.6 billion cash acquisition at $124 per share, reflecting a 40% premium to the last close. The deal highlights GSK's strategic move to expand its oncology portfolio beyond its current 6% share of sales, aiming to capitalize on Nuvalent's two lung cancer drugs pending FDA decisions this year. The tender offer needs the approval of at least half of Nuvalent's Class A shares and U.S. antitrust clearance. Early analyst reactions included target price adjustments but echoed caution over valuation. Nuvalent's pipeline products could face competition from existing ALK-targeted therapies by Pfizer and Roche.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Go toTop